Why Did 180 Life Sciences Corp. (ATNF) Soar 31.45%?

Generated by AI AgentAinvest Pre-Market Radar
Tuesday, Aug 5, 2025 5:00 am ET1min read
Aime RobotAime Summary

- 180 Life Sciences (ATNF) surged 31.45% pre-market after securing $425M in private funding to pivot to Ethereum-focused treasury operations.

- The rebranded ETHZilla transition from biotech/iGaming to crypto has generated strong market confidence in its Ethereum strategy.

- Investors view the capital infusion as a catalyst for shareholder value through strategic Ethereum asset allocation and ecosystem positioning.

180 Life Sciences Corp. (NASDAQ: ATNF) has seen a remarkable surge in its stock price, rising by 31.45% in pre-market trading on August 5, 2025. This significant increase comes on the heels of several strategic moves by the company, which have garnered substantial attention from investors.

180 Life Sciences has recently closed a $425 million private placement, a move aimed at bolstering its Ethereum strategy. This substantial funding round is part of the company's pivot from biotech and iGaming to becoming a dedicated Ethereum treasury vehicle. The company's rebranding to ETHZilla and its focus on Ethereum have been well-received by the market, reflecting a growing interest in cryptocurrency investments.

The company's strategic shift has been met with positive market sentiment, as evidenced by the surge in its stock price. The private placement not only provides the company with the necessary capital to advance its Ethereum treasury strategy but also signals a strong commitment to the cryptocurrency sector. This move is expected to enhance value for shareholders and position

Sciences as a key player in the Ethereum ecosystem.

Comments



Add a public comment...
No comments

No comments yet